Stock listing
NASDAQ:PNT POINT Biopharma Global Inc Stock
Follow POINT Biopharma Global Inc into a list and get an email when it puts out news.
Last close · NASDAQ:PNT
$12.50 USD
Close on Dec 29, 2023 · No longer trades
- Lowest – highest close
- $4.83 – $16.86 USDSince Jul 8, 2020 · lowest Dec 16, 2021 · highest Feb 11, 2021
Delisted NASDAQ:PNT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PNT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
POINT Biopharma Global Inc on 6ix
- Decks
- 3 decks · latest Feb 25, 2022
Where POINT Biopharma Global Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PNT · This page · Delisted | NASDAQ | United States | USD |
| NASDAQ:RACA · Delisted | NASDAQ | United States | USD |
| NASDAQ:TXAC · Delisted | NASDAQ | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (February 2022) | Investor deck | 47 slides | Feb 25, 2022 |
| Investor Presentation (November 2021) | Investor deck | 41 slides | Nov 19, 2021 |
| SPAC Merger (March 2021) | SPAC merger | 26 slides | Mar 15, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Jun 23, 2021 – Jun 29, 2021 · Past |
| Bridget Martell Other companies: Delcath Systems, Inc. (Director · Since at least May 23, 2024); Aligos Therapeutics, Inc. (Director · Since at least Nov 16, 2021); Achieve Life Sciences, Inc. (Director · Since at least Mar 15, 2021); Ayala Pharmaceuticals Inc (Director · Oct 18, 2023 – Oct 18, 2023 · Past); Kura Oncology, Inc. (Acting Chief Medical Officer · Feb 10, 2020 – Aug 24, 2020 · Past) | Director · Jun 12, 2023 – Jun 13, 2023 · Past |
| Michael Gray Other companies: Upstream Bio, Inc. (CFO and COO · Since at least Oct 10, 2024); Enliven Therapeutics, Inc. (CFO & COO · Mar 11, 2020 – Feb 22, 2023 · Past); X4 Pharmaceuticals, Inc. (President, CEO and CFO, Director · Nov 15, 2017 – Nov 27, 2018 · Past) | Director · Jul 7, 2020 – Jul 7, 2020 · Past |
| Allan C Silber | Executive Chairman, Director · Jun 30, 2021 – Dec 22, 2023 · Past |
| Gerald L Hogue | Director · Jun 30, 2021 – Dec 26, 2023 · Past |
| Jessica D Jensen | EVP Clinical Development · Jun 30, 2021 – Dec 27, 2023 · Past |
| Joe A McCann | Chief Executive Officer, Director · Jun 30, 2021 – Dec 22, 2023 · Past |
| Jonathan R Goodman | Director · Jun 2, 2022 – Dec 26, 2023 · Past |
| William L Demers | Chief Financial Officer · Jun 30, 2021 – Dec 27, 2023 · Past |
Log in to ask 6ix AI your own questions about POINT Biopharma Global Inc.